Français Japonais Chinois Allemand Néerlandais Espagnol Portugais

    News

    Grid opens new audiovisual studio in Greater Lille

    Belgium-based Grid has opted to open its third office in Hauts-de-France—proof that Lille’s highly developed digital ecosystem is a strong selling point for animation studios.

    Booking.com renews commitment to Tourcoing

    Booking.com has signed a deal for a new building in Tourcoing, making good on plans announced in April. Find out why the fast-growing online travel company chose to stay in Hauts-de-France.

    All news

    Worldwide innovation—Cousin Biotech develops pain-relieving implant

    03 Oct 2017 | Front page, Advanced Materials, A region on the move

    Cousin Biotech, a specialist in technical textiles for medical applications based in Hauts-de-France, has developed an implant that can replace oral pain medication after inguinal hernia surgery.

    textiles, medical, innovation

    Worldwide first

    After seven years of research and development, Cousin Biotech has created an innovative implant that can replace oral pain medication in patients with inguinal hernias. Analgesic compounds are grafted onto the fabric of the implant, which is placed directly on the painful area after surgery and diffuses painkillers into the body. In 12% of patients, the implant is expected to outperform pills in managing post-operative pain.

    There are already implants for this type of operation, but none of them can release painkillers into the body after surgery,” says CEO François Tortel.

    Successful differentiation strategy

    Based in Wervicq-Sud, Cousin Frères Group has made innovation a watchword. In 1989 the company embraced the trend toward medical applications for technical textiles, then founded Cousin Biotech in 1995 to adapt its expertise for new markets.

    To compete successfully with major international players in the industry, Cousin Biotech has focused on making the surgeon’s job easier and improving quality of life for patients.

    Major market potential

    Cousin Biotech does business in 61 countries and sells over 400 different medical products: every three minutes, a Cousin Biotech implant is placed somewhere around the world.

    With this latest innovation, the company is targeting major international markets. Some 2 million inguinal hernia operations are performed annually, including 140,000 in France.

    In two years, Cousin Biotech will have the necessary regulatory approvals from the European Union, and can begin marketing its implant, first in Europe and then worldwide.

     

    Source: CCI Nord de France, Cousin Biotech

    Back to news